$LIEN

Chicago Atlantic BDC, Inc. (LIEN): Results of Operations and Financial Condition

Chicago Atlantic BDC, Inc. (LIEN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Chicago Atlantic BDC, Inc. Reports Second Quarter 2026 Financial Results NEW YORK, August 13, 2026 — Chicago Atlantic BDC, Inc. (“LIEN” or the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, t

Original reporting
Published Aug 13, 2026, 11:02 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 11:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$LIEN
Neutral
medium confidence
Mentioned
$LIEN · $REFI
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$LIENNeutralMed
01

Why it matters

Traders can update models for quarterly earnings power (net investment income), balance-sheet capacity (liquidity and credit facility availability), and forward catalysts (Q3 dividend payment and expected Q4 merger close).

02

Market read

Primary disclosures include Q2 income and NAV updates, a declared dividend, and merger terms that can drive deal-probability and valuation repricing.

03

What to watch

Merger completion depends on multiple approvals and the exchange ratio will be recalculated near closing, which can materially change implied ownership and valuation.

Relevance 7/10Novelty 7/10Timing: today’s SEC 8-K with Q2 results, dividend declaration, and merger terms

Background

This is an SEC Form 8-K (Item 2.02) with Exhibit 99.1 reporting LIEN’s Q2 2026 financial results and describing a previously announced merger with REFI, plus a declared dividend.

Company-level read

Ticker impact

$LIENNeutralMedium confidence
Context

LIEN reports Q2 2026 results, including net investment income of $7.7 million and NAV per share of $13.26, plus liquidity of $73.9 million.

Expected impact

Moderate two-sided reaction risk, with upside bias if investors focus on 0.0% non-accruals and strong yield, and downside if they focus on NAV decline and asset shrink.

Evidence & confidence

The filing is a primary disclosure with multiple tradable datapoints: quarterly income, NAV per share movement, liquidity/credit availability, and a stated expected merger close in Q4 2026.

$REFINeutralMedium confidence
Context

REFI is named as the merger counterparty, with REFI stockholders expected to own about 50.5% of LIEN post-merger based on March 31, 2026 NAVs.

Expected impact

Potentially positive bias on deal optionality, but volatility likely around exchange ratio mechanics and required approvals.

Evidence & confidence

The article discloses deal terms, expected close timing (Q4 2026), and key conditions, which can re-rate the probability-weighted outcome for REFI.

Market effects

BDC and specialty finance investors may reprice risk based on LIEN’s 0.0% non-accruals and 16.0% weighted average debt yield.

None material beyond US-listed BDC sentiment.

Limited, deal and results are primarily US-focused.

Counterpoint

The NAV per share declined to $13.26 from $13.33, and asset totals fell, so the income strength may not fully offset balance-sheet contraction.

Key entities

  • Chicago Atlantic BDC, Inc.

    Subject of the filing, reporting Q2 2026 results, liquidity, dividend, and the merger as the surviving company.

  • Chicago Atlantic Real Estate Finance, Inc.

    Merger counterparty that will elect BDC regulation prior to merging into LIEN.

Related articles

$REFIMed

Chicago Atlantic (REFI) Q2 2026 Earnings Call Transcript

Chicago Atlantic Real Estate Finance (REFI) reported Q2 2026 earnings with net interest income down 2.2% to $12.8M, but loan principal up to $453.1M. Earnings per share were $0.44, below the $0.47 dividend. Management highlighted a merger with Chicago Atlantic BDC and expansion into retail sale-leaseback via Koach Capital, maintaining full-year dividend outlook.

$REFIMed

Chicago Atlantic Real Estate Finance, Inc. Q2 2026 Earnings Call Summary

Chicago Atlantic Real Estate Finance (REFI) reported Q2 2026 distributable earnings of $0.44 per share, below the dividend, citing timing of $16.3 million in early loan prepayments. Management discussed a proposed merger with LIEN expected in Q4 2026, a Koach Capital cannabis sale-leaseback exposure, and a 90% to 100% payout target for 2026.

$REFIMed

Chicago Atlantic Real Estate Finance, Inc. (REFI): Results of Operations and Financial Condition

Chicago Atlantic Real Estate Finance, Inc. (REFI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Chicago Atlantic Real Estate Finance Announces Second Quarter 2026 Financial Results CHICAGO— (August 11, 2026) Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI, “Chicago Atlantic”, “REFI” or the “Company”), a commercial mortgage real estate investment trust,

$SNOWHighAI 9/10

Snowflake Inc. (SNOW): Results of Operations and Financial Condition

Snowflake Inc. (SNOW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Snowflake Reports Financial Results for the Second Quarter of Fiscal 2027 Product revenue of $1.49 billion in the second quarter, representing 37% year-over-year growth Financial Highlights: • Revenue of $1.55 billion in the second quarter, representing 35% year-over-year growth

$SCTXHigh

Scribe Therapeutics, Inc. (SCTX): Results of Operations and Financial Condition

Scribe Therapeutics, Inc. (SCTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights Initiated the first-in-human Phase 1 trial of STX-1150, a novel LDL-C lowering therapy powered by ELXR, a highly engineered epigenetic silencing technology designed to d